SNES — SenesTech, Inc.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Company profile
- Sector: Basic Materials
- Industry: Chemicals - Specialty
- Country: US
- Exchange: NASDAQ
- Employees: 23
- Website: https://www.senestech.com
Latest SEC filings for SNES
- SCHEDULE 13D/A — 2026-10-22
- SCHEDULE 13D/A — 2026-10-19
- SCHEDULE 13D — 2026-07-23
- 8-K — 2026-06-10
- 10-Q — 2026-05-13
- 8-K — 2026-05-12
- 8-K — 2026-05-07
- SCHEDULE 13G/A — 2026-03-18
- 10-K — 2026-03-13
- 8-K — 2026-03-12
Latest SNES news
- — SenesTech Reports Record Preliminary Q3 Revenue of $1.1 Million - Quiver Quantitative (Quiver Quantitative)
- — Preliminary Q3 revenue rises about 55% year over year at SenesTech (SNES) to a quarterly high. - Stock Titan (Stock Titan)
- — SenesTech (SNES) Reports Q3 Revenue Surge Past $1 Million Mark - GuruFocus (GuruFocus)
- — SenesTech stock dips even as preliminary Q3 revenue crosses $1M milestone - TradingView (TradingView)
- — SenesTech stock dips even as preliminary Q3 revenue crosses $1M milestone (seekingalpha_market)
- — A first for SenesTech: quarterly revenue tops $1 million - Stock Titan (Stock Titan)
- — SenesTech shifts to rodent birth control: what it means for SenesTech stock - ad-hoc-news.de (ad-hoc-news.de)
Educational tool only — not investment advice.